Abstract

Introduction Endoscopic resection (ER) exceeding ≥75% of the esophageal circumference is accompanied with a high stricture risk regardless of the resection method. The ideal strategy for stricture prevention is not well defined today. Different approaches have been reported but data are limited to the resection of squamous cell neoplasia. The aim of this study was to assess the efficacy of an individualized oral steroid regimen to prevent strictures after extensive ER in neoplastic Barrett's esophagus (NBE). Materials and Methods Over a 50-month period, endoscopic submucosal dissection (ESD) was performed in 193 patients with NBE. 23 patients with resections exceeding 75% of the circumference were included. 19 resection ulcers were noncircumferential (NCR) while 4 were circumferential (CR). Stricture prevention was performed using oral prednisolone starting with a daily dose of 50 mg and standard tapering over 8 weeks (50/40/30/25/20/15/10/5 mg). Tapering was individualized according to the ulcer healing process (assessed endoscopically in the first tapering period and before stopping the steroids). Data were analyzed retrospectively. Results Stricture rates were 5.3% (1/19) for NCR and 100% (4/4) for CR (p < 0.001). The only stricture in the NCR group was seen in a patient who had stopped steroids without any reason after few days. 12/19 patients received standard tapering over 8 weeks (63.1%). According to the individual ulcer healing, treatment was prolonged to 9-10 weeks in 4/19 (21.1%) and shortened to 7 weeks in another 2/19 (10.5%). After CR, all patients needed endoscopic balloon dilatation (median 6.5 sessions; range 3-14 sessions for 8-40 weeks). Side effects of the steroid therapy were not noted. Conclusion Oral prednisolone therapy with an endoscopy-based individualized tapering regimen is effective in avoiding strictures after NCR of Barrett's neoplasia. After CR, the stricture risk is not sufficiently decreased. CR should be restricted to circumferential neoplasia which is a very rare scenario in neoplastic BE.

Highlights

  • Endoscopic resection (ER) exceeding ≥75% of the esophageal circumference is accompanied with a high stricture risk regardless of the resection method

  • Over a 50-month period, 193 endoscopic submucosal dissection (ESD) procedures were performed for neoplastic Barrett’s esophagus (BE). 27 resection ulcers exceeded ≥75% of the circumference (13.7%)

  • Three patients were excluded because they had received additional intralesional triamcinolone injection during the first study period. Another patient was excluded because of permanent steroid treatment performed for rheumatoid arthritis. 23 patients who started the proposed stricture prevention regimen were included for further analysis

Read more

Summary

Introduction

Endoscopic resection (ER) exceeding ≥75% of the esophageal circumference is accompanied with a high stricture risk regardless of the resection method. The aim of this study was to assess the efficacy of an individualized oral steroid regimen to prevent strictures after extensive ER in neoplastic Barrett’s esophagus (NBE). Oral prednisolone therapy with an endoscopy-based individualized tapering regimen is effective in avoiding strictures after NCR of Barrett’s neoplasia. In selected neoplasia (lesion diameter exceeding 15 mm, poor-lifting lesions, and lesions at risk for submucosal invasion), endoscopic submucosal dissection (ESD) can be considered as a treatment option in order to achieve R0 resection and to improve histopathological assessment of R0 resection [2]. When ER is performed circumferentially or the resection area exceeds three quarters of the circumference, a substantial stricture risk has been reported for EMR (49.7-88%) and for ESD (60.0%) in BE [3,4,5]. Different strategies have been introduced to prevent stricture development (balloon dilatation, stenting, local or systemic steroid therapy in fixed-dosage regimens, and tissue-shielding techniques)

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call